Paper Details

  1. Home
  2. Paper Details

Aromatase inhibitors for subfertile women with polycystic ovary syndrome.

Author: FarquharCindy, FranikSebastian, KremerJan A M, NelenWillianne L D M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Polycystic ovary syndrome (PCOS) is a common condition that can cause irregular periods and difficulty getting pregnant. While a medication called clomiphene citrate (CC) is often used to help women with PCOS ovulate, a newer type of medication, aromatase inhibitors (AIs), has been investigated. Studies have found mixed results on whether the AI letrozole is as effective as CC.
Paper Details　
Original Abstract of the Article :
Polycystic ovary syndrome (PCOS) is the most common cause of infrequent periods (oligomenorrhoea) and absence of periods (amenorrhoea). It affects about 4% to 8% of women worldwide and often leads to anovulatory subfertility. Aromatase inhibitors (AIs) are a novel class of drugs that were introduced...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD010287.pub2

データ提供：米国国立医学図書館（NLM）

Aromatase Inhibitors for PCOS: A New Frontier in Fertility

Polycystic ovary syndrome (PCOS), a common hormonal disorder, can affect fertility. This review explores the use of aromatase inhibitors (AIs) in treating anovulatory subfertility associated with PCOS. The review focuses on letrozole, an AI, and compares its effectiveness to clomiphene citrate (CC), the first-line treatment for ovulation induction. Clinical trials have yielded conflicting results regarding the comparative efficacy of letrozole versus CC. While some studies suggest that letrozole may be at least as effective as CC, others have shown less consistent results. The review highlights the need for further research to clarify the role of AIs in managing PCOS-related subfertility.

Navigating the Desert of PCOS: Finding the Right Path to Fertility

Imagine you're a traveler in a vast desert, seeking a path to a fertile oasis. Similarly, women with PCOS face the challenge of navigating their reproductive journey, often seeking treatments to overcome anovulatory subfertility. This review explores the use of aromatase inhibitors (AIs) as a potential path towards fertility. While some studies suggest that letrozole, an AI, may be as effective as clomiphene citrate (CC), the first-line treatment, further research is needed to definitively establish its role in managing PCOS-related subfertility.

Aromatase Inhibitors: A Potential Path to Fertility

This review highlights the potential of AIs as a treatment option for PCOS-related subfertility. However, it also emphasizes the need for further research to clarify their efficacy and safety profile. Working closely with a reproductive endocrinologist is crucial to determine the best treatment approach for your individual needs and circumstances. Remember, the journey to fertility can be complex and often requires a multi-faceted approach, involving both medication and lifestyle modifications.

Dr.Camel's Conclusion

This review sheds light on the use of aromatase inhibitors (AIs) in treating PCOS-related subfertility. While some studies suggest potential benefits, further research is needed to definitively establish their role in managing this complex condition. As a researcher, I am encouraged by the ongoing exploration of new treatment options for PCOS and the pursuit of improved fertility outcomes for women affected by this disorder. The journey to fertility can be challenging, but with continued research and personalized care, we can strive to provide women with the best possible options for achieving their reproductive goals.

Date :
  1. Date Completed 2014-10-08
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

24563180

DOI: Digital Object Identifier

10.1002/14651858.CD010287.pub2

Related Literature

Article Analysis
・Effective treatment of polycystic ovary syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.